DNA vaccines expressing antigens with a stress protein-capturing domain display enhanced immunogenicity

Immunological Reviews

Volumn 199, Issue , 2004, Pages 54-67

  Reimann, Jörg ^a   Schirmbeck, Reinhold ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHIMERIC PROTEIN; DNA VACCINE; EPITOPE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 73; MUTANT PROTEIN; TUMOR ANTIGEN;

AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELLULAR IMMUNITY; DNA PROBE; HALF LIFE TIME; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TUMOR CELL;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS; HEAT-SHOCK PROTEINS; HSP40 HEAT-SHOCK PROTEINS; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

EID: 2942571812     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.00136.x     Document Type: Review

References (118)

1. Wild J, et al. Polyvalent vaccination against hepatitis B surface and core antigen using dicistronic expression plasmids. Vaccine 1998;16:353-360.
2. Hennecke M, et al. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 2001;29:3327-3334.
3. Kwissa M, Unsinger J, Schirmbeck R, Hauser H, Reimann J. Polyvalent DNA vaccines with bidirectional promoters. J Mol Med 2000;78:495-506.
4. Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997;158:4137-4144.
5. Chen CH, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000;60:1035-1042.
6. Scheerlinck JY. Genetic adjuvants for DNA vaccines. Vaccine 2001;19:2647-2656.
7. Mendoza RB, Cantwell MJ, Kipps TJ. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J Immunol 1997;159:5777-5781.
8. Gurunathan S, et al. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol 1998;161:4563-4571.
9. Deliyannis G, Boyle JS, Brady JL, Brown LE, Lew AM. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc Natl Acad Sci USA 2000;97:6676-6680.
10. + T cell responses by effects on dendritic cells. J Immunol 2001;167:3592-3599.
11. Sasaki S, Amara RR, Yeow WS, Pitha PM, Robinson HL. Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J Virol 2002;76:6652-6659.
12. Schirmbeck R, Reimann J. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 1994;24:1478-1486.
13. Schirmbeck R, Bōhm W, Reimann J. Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentation. Eur J Immunol 1997;27:2016-2023.
14. Gurney EG, Tamowsky S, Deppert W. Antigenic binding site of monoclonal antibodies specific for simian virus 40 large T antigen. J Virol 1986;57:1168-1172.
15. Grussenmeyer J, Scheidtmann KH, Hutchinson MA, Eckhart W, Walter G. Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci USA 1985;82:7952-7954.
16. Walter G, Carbone A, Welch WJ. Medium tumor antigen of polyoma virus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein. J Virol 1987;61:405-410.
17. Sawai ET, Butel JS. Association of heat shock proteins with the SV40 large T antigen. J Virol 1989;63:3961-3973.
18. Schirmbeck R, Kwissa M, Fissolo N, Elkholy S, Riedl P, Reimann J. Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain. FASEB J 2002;16:1108-1110.
19. Hightower LE, Sadis SE, Takenaka IM. Interaction of vertebrate hsc70 and hsp70 with unfolded proteins and peptides. In: Morimoto RI, Tissieres A, Georgopoulos C, eds. The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor: CSHL Press, 1994: 179-207.
20. King C, Eisenberg E, Greene LE. Interaction between Hsc70 and DnaJ homologues: relationship between Hsc70 polymerization and ATPase activity. Biochemistry 1999;38:12452-12459.
21. Schirmbeck R, Gerstner O, Reimann J. Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expression. Eur J Immunol 1999;29:1740-1749.
22. Miyaji EN, et al. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae. Vaccine 2001;20:805-812.
23. Riedl P, El Kholy S, Reimann J, Schirmbeck R. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination. J Immunol 2002;169:1251-1260.
24. b-restricted HBsAg epitopes. J Immunol 2002;168:6253-6262.
25. + T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. J Immunol 2003;171:1140-1246.
26. Happ MP, Kubo RT, Palmer E, Born W, O'Brien RL. Limited receptor repertoire in a mycobacteria-reactive subset of γδ T lymphocytes. Nature 1989;342:696-698.
27. Modlin RL, et al. Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions. Nature 1989;339:544-548.
28. Janson AAM, et al. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients: Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells. J Immunol 1991;147:3530-3537.
29. Mehra V, et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 1992;175:275-284.
30. Fu Y-X, Cranfill R, Vollmer M, van der Zee R, O'Brien RL, Born W. In vivo response of murine γδ T cells to a heat shock protein-derived peptide. Proc Natl Acad Sci USA 1993;90:322-326.
31. Paul AG, van Kooten PJ, van Eden W, van der Zee R. Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFNγ and are protective in adjuvant arthritis. J Immunol 2000;165:7270-7277.
32. Morrison RP, Belland RJ, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989;170:1271-1283.
33. + T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles. J Immunol 2000;164:1529-1537.
34. Sanchez GI, et al. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice. Infect Immun 2001;69:3897-3905.
35. Rico AI, Angel SO, Alonso C, Requena JM. Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol 1999;36:1131-1139.
36. Konen-Waisman S, Fridkin M, Cohen IR. Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen. J Immunol 1995;154:5977-5985.
37. Steinhoff U, et al. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity 1999;11:349-358.
38. Davies A, et al. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm. J Immunol 2003;170:5027-5033.
39. Suzue K, Young R. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 1996;156:873-879.
40. Suzue K, Zhou X, Eisen HN, Young R. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA 1997;94:13146-13151.
41. + T cell independent. J Exp Med 2000;191:403-408.
42. Udono H, Yamano T, Kawabata Y, Ueda M, Yui K. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol 2001;13:1233-1242.
43. Cho BK, et al. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. Immunity 2000;12:263-272.
44. Liu DW, et al. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J Virol 2000;74:2888-2894.
45. Cheng WF, et al. Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. J Immunol 2001;166:6218-6226.
46. Moroi Y, et al. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc Natl Acad Sci USA 2000;97:3485-3490.
47. Strbo N, Oizumi S, Sotosek-Tokmadzic V, Podack ER. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 2003;18:381-390.
48. Arnold-Schild D, Spehner D, Schmid C, Rammensee HG, de la Salle H, Schild H. Receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 1999;162:3757-3760.
49. Singh JH, et al. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 2000;191:1965-1974.
50. Sondermann H, Becker T, Mayhew M, Wieland F, Hartl FU. Characterization of a receptor for heat shock protein 70 on macrophages and monocytes. Biol Chem 2000;381:1165-1174.
51. Lipsker D, et al. Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells. Eur J Immunol 2002;32:322-332.
52. Arnold-Schild D, Faath S, Rammensee HG, Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995;182:885-889.
53. Basu S, Srivastava P. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med 1999;189:797-802.
54. Asea A, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000;6:435-442.
55. Vabulas RM, et al. Endocytosed heat shock protein 60s use TLR2 and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001;276:31332-31339.
56. Binder RJ, Han DK, Srivastava P. CD91: a receptor for heat shock protein gp96. Nat Immunol 2000;1:151-155.
57. Basu S, Binder RJ, Ramalingam T, Srivastava P. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001;14:303-313.
58. Delneste Y, et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002;17:353-362.
59. Tabona P, et al. Homogeneous Escherichia coli chaperonin 60 induces IL-1b and IL-6 gene expression in human monocytes by a mechanism independent of protein conformation. J Immunol 1998;161:1414-1421.
60. Byrd CA, et al. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1999;96:5645-5650.
61. Kol A, Bourcier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999;103:571-577.
62. + cells in vivo. J Immunol 2000;165:6029-6035.
63. Singh JH, et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 2000;30:2211-2215.
64. Wallin RP, Lundqvist A, More SH, Von Bonin A, Kiessling R, Ljunggren HG. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002;23:130-135.
65. Todryk S, et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 1999;163:1398-1408.
66. Lehner T, Bergmeier LA, Wang Y, Tao L, Sing M, Spallek R, van der Zee R. Heat shock proteins generate b-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol 2000;30:594-603.
67. Panjwani NN, Popova L, Srivastava P. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol 2002;168:2997-3003.
68. Breloer M, Fleischer B, Von Bonin A. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins. J Immunol 1999;162:3141-3147.
69. Lakey EK, Margoliash E, Pierce SK. Identification of a peptide-binding protein having a role in antigen presentation. Proc Natl Acad Sci USA 1987;84:1659-1667.
70. VanBuskirk AM, DeNagel DC, Guagliardi LE, Brodsky FM, Pierce SK. Cellular and subcellular distribution of PBP72/74, a peptide- binding protein that plays a role in antigen processing. J Immunol 1991;146:500-506.
71. Domanico SZ, DeNagel DC, Dahlseid JN, Green JM, Pierce SK. Cloning of the gene encoding peptide-binding protein 74 shows that it is a new member of the heat shock protein 70 family. Mol Cell Biol 1993;13:3598-3610.
72. Panjwani N, Akbari O, Garcia S, Brazil M, Stockinger B. The HSC73 molecular chaperone: involvement in MHC class II antigen presentation. J Immunol 1999;163:1936-1942.
73. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994;12:259-294.
74. Lindner R, Unanue ER, Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J 1996;15:6910-6920.
75. Ma C, Blum JS. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. J Immunol 1997;158:1-4.
76. Sercarz EE, Maverakis E. MHC-guided processing: binding of large antigen fragments. Nat Rev Immunol 2003;3:621-629.
77. Binder RJ, Blachere NE, Srivastava P. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by MHC I molecules. J Biol Chem 2001;276:17163-17171.
78. Ishii T, et al. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol 1999;162:1303-1309.
79. Lammert E, Arnold-Schild D, Rammensee HG, Schild H. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation. Eur J Immunol 1996;26:875-879.
80. Suto R, Srivastava P. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995;269:1585-1588.
81. + T cells in vivo. J Immunol 2002;169:5622-5629.
82. Chandawarkar RY, Wagh MS, Srivastava P. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med 1999;189:1437-1442.
83. Nieland TJF, Tan MCA, van Muijen MM, Koning F, Kruisbeek AM, van Bleek GM. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc Natl Acad Sci USA 1996;93:6135-6139.
84. Roman E, Moreno C. Synthetic peptides non-covalendy bound to bacterial hsp70 elicit peptide-specific T-cell responses in vivo. Immunology 1996;88:487-492.
85. Heikema A, Agsteribbe E, Wilschut J, Huckriede A. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides. Immunol Lett 1997;57:69-74.
86. Ciupitu AM, et al. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med 1998;187:685-691.
87. Meng SD, Gao T, Gao GF, Tien P. HBV-specific peptide associated with heat-shock protein gp96. Lancet 2001;357:528-529.
88. Kumaraguru U, Gierynska M, Norman S, Bruce BD, Rouse BT. Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection. J Virol 2002;76:136-141.
89. Udono H, Srivastava P. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993;178:1391-1396.
90. Udono H, Srivastava P. Comparison of tumor-specific immunogenicity of stress-induced protein gp96, hsp90, and hsp70. J Immunol 1994;152:5398-5403.
91. Feldweg AM, Srivastava P. Molecular heterogeneity of tumor rejection antigen/heat shock protein GP96. Int J Cancer 1995;63:310-314.
92. Blachere NE, et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 1997;186:1315-1322.
93. Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001;166:490-497.
94. Dai J, et al. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory. Cancer Immun 2003;3:1-11.
95. Kumaraguru U, Rouse RJ, Nair SK, Bruce BD, Rouse BT. Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization. J Immunol 2000;165:750-759.
96. Thery C, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999;147:599-610.
97. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000;12:1539-1546.
98. Dice JF, Agarraberes F, Kirven-Brooks M, Terlecky LJ, Terlecky SR. Heat shock 70-kD proteins and lysosomal proteolysis. In: Morimoto RI, Tissieres A, Georgopoulos C, eds. The Biology of Heat Schock Proteins and Molecular Chaperones. Cold Spring Harbor: CSHL Press, 1994: 137-151.
99. Dice JF, Terlecky SR. Selective degradation of cytosolic proteins by lysosomes. In: Ciechanover AJ, Schwartz AS, eds. Cellular Proteolytic Systems. New York: Wiley-liss, 1994: 55-64.
100. Hayes SA, Dice JF. Roles of molecular chaperones in protein degradation. J Cell Biol 1996;132:255-258.
101. Cuervo AM, Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996;273:501-503.
102. b-restricted epitopes in natural variants of the hepatitis B surface antigen. Eur J Immunol 2003;33:2429-2436.
103. El Kholy S, Riedl P, Kwissa M, Reimann J, Schirmbeck R. Selective expression of immunogenic, VIP-derived epitopes binding antibodies. Intervirology 2002;45:251-259.
104. Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996;184:1555-1560.
105. Doe B, Selby M, Barnett S, Baenziger J, Walker CM. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 1996;93:8578-8583.
106. Ulmer JB, Deck RR, DeWitt CM, Donnhly JI, Liu MA. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 1996;89:59-67.
107. Fu TM, et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 1997;3:362-371.
108. Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997;159:11-14.
109. Corr M, von-Damm A, Lee DJ, Tighe H. In vivo priming by DNA injection occurs predominantly by antigen transfer. J Immunol 1999;163:4721-4727.
110. + T cells to tumor cell antigens by dendritic cells. J Immunol 2002;168:108-117.
111. Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature 1995;377:632-635.
112. Piedrafita D, Xu D, Hunter D, Harrison RA, Liew FY. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major. J Immunol 1999;163:1467-1472.
113. Martinon F, et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol 1993;23:1719-1722.
114. Watanabe A, et al. Induction of antibodies to a κV region by gene immunization. J Immunol 1993;151:2871-2876.
115. Hawkins RE, et al. Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 1994;83:3279-3288.
116. Krasemann S, Groschup M, Hunsmann G, Bodemer W. Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice. J Immunol Methods 1996;199:109-118.
117. Schirmbeck R, Böhm W, Ando K-I, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995;69:5929-5934.
118. Schirmbeck R, et al. Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants. Eur J Immunol 2003;33:3342-3352.